JP2015518494A - 室温安定性ドロナビノールカプセルの製造および包装 - Google Patents

室温安定性ドロナビノールカプセルの製造および包装 Download PDF

Info

Publication number
JP2015518494A
JP2015518494A JP2015511473A JP2015511473A JP2015518494A JP 2015518494 A JP2015518494 A JP 2015518494A JP 2015511473 A JP2015511473 A JP 2015511473A JP 2015511473 A JP2015511473 A JP 2015511473A JP 2015518494 A JP2015518494 A JP 2015518494A
Authority
JP
Japan
Prior art keywords
cannabinoid
packaging
capsule
inert gas
liquefied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015511473A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518494A5 (enExample
Inventor
ゴスコンダ、ベンカット
チャヴァン、アショック
アマンチャ、キーラン
クリスマン、スコット
ロペス、クリスタル
Original Assignee
インシス セラピューティクス、インク．
インシス セラピューティクス、インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インシス セラピューティクス、インク．, インシス セラピューティクス、インク． filed Critical インシス セラピューティクス、インク．
Publication of JP2015518494A publication Critical patent/JP2015518494A/ja
Publication of JP2015518494A5 publication Critical patent/JP2015518494A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2015511473A 2012-05-07 2013-03-27 室温安定性ドロナビノールカプセルの製造および包装 Pending JP2015518494A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261643713P 2012-05-07 2012-05-07
US61/643,713 2012-05-07
PCT/US2013/033991 WO2013169406A1 (en) 2012-05-07 2013-03-27 Manufacturing and packaging room temperature stable dronabinol capsules

Publications (2)

Publication Number Publication Date
JP2015518494A true JP2015518494A (ja) 2015-07-02
JP2015518494A5 JP2015518494A5 (enExample) 2016-04-21

Family

ID=49513014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015511473A Pending JP2015518494A (ja) 2012-05-07 2013-03-27 室温安定性ドロナビノールカプセルの製造および包装

Country Status (5)

Country Link
US (1) US8741341B2 (enExample)
EP (1) EP2846782A4 (enExample)
JP (1) JP2015518494A (enExample)
CA (1) CA2872248A1 (enExample)
WO (1) WO2013169406A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022085622A1 (ja) * 2020-10-23 2022-04-28 富士カプセル株式会社 カンナビジオール含有シームレスソフトカプセル

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
ES2835720T3 (es) * 2014-06-11 2021-06-23 Poviva Corp Composiciones de alimentos y bebidas infusionadas con agentes activos lipófilos y métodos de uso de las mismas
EP3164141B1 (en) 2014-06-11 2020-11-11 Poviva Corp. Food and beverage compositions infused with lipophilic active agents and methods of use thereof
CA3176674A1 (en) 2015-05-18 2016-11-24 5071, Inc. Homogenous cannabis compositions and methods of making the same
ES2938560T3 (es) * 2015-05-28 2023-04-12 Radius Pharmaceuticals Inc Formulaciones de cannabinoides estables
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3737371A4 (en) * 2018-01-10 2021-10-06 Benuvia Therapeutics, LLC DRONABINOL STABILIZATION PROCESSES
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
US20230001128A1 (en) * 2019-11-25 2023-01-05 Gary Stephen Shuster Aerosolization systems, methods, and apparatuses
WO2021216475A1 (en) 2020-04-20 2021-10-28 Poviva Corp. Compositions and methods for enhanced delivery of antiviral agents
EP4591855A1 (en) 2024-01-23 2025-07-30 Echo Pharmaceuticals B.V. Stable dronabinol compositions

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4917671U (enExample) * 1972-05-17 1974-02-14
JPS60183374A (ja) * 1984-02-24 1985-09-18 大日本印刷株式会社 脱酸素密封包装物の製造法
JP2005521710A (ja) * 2002-04-03 2005-07-21 ソルベイ・フアーマシユーチカルズ・ベー・ブイ 安定化された天然カンナビノイド調剤
JP2005296381A (ja) * 2004-04-13 2005-10-27 Nippon Kayaku Co Ltd カプセル剤の保存容器並びに保存方法
JP2006504671A (ja) * 2002-08-14 2006-02-09 ジーダブリュー ファーマ リミテッド 粘膜投与のためのカンナビノイド液体製剤
JP2006206583A (ja) * 2004-12-28 2006-08-10 Kaneka Corp 還元型補酵素ｑ１０の保存方法
JP2008523078A (ja) * 2004-12-09 2008-07-03 インシス セラピューティクス，インコーポレーテッド 室温で安定なドロナビノール製剤
US20090169586A1 (en) * 2006-03-24 2009-07-02 Ian Simon Tracton Stable packaged dosage form and process therefor
JP2010509292A (ja) * 2006-11-10 2010-03-25 ジョンソン、マッセイ、パブリック、リミテッド、カンパニー （−）−δ９−トランス−テトラヒドロカンナビノールを含んでなる組成物
JP2010535774A (ja) * 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
US20120043242A1 (en) * 2010-08-19 2012-02-23 Andrew David Hospodor Medicinal cannabis fatty foodstuff

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7633097B2 (en) 2004-09-23 2009-12-15 Philips Lumileds Lighting Company, Llc Growth of III-nitride light emitting devices on textured substrates
US8222292B2 (en) 2007-08-06 2012-07-17 Insys Therapeutics, Inc. Liquid cannabinoid formulations
EP2621509A4 (en) 2010-09-15 2016-08-03 Synergy Pharmaceuticals Inc FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHOD OF USE

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4917671U (enExample) * 1972-05-17 1974-02-14
JPS60183374A (ja) * 1984-02-24 1985-09-18 大日本印刷株式会社 脱酸素密封包装物の製造法
JP2005521710A (ja) * 2002-04-03 2005-07-21 ソルベイ・フアーマシユーチカルズ・ベー・ブイ 安定化された天然カンナビノイド調剤
JP2006504671A (ja) * 2002-08-14 2006-02-09 ジーダブリュー ファーマ リミテッド 粘膜投与のためのカンナビノイド液体製剤
JP2005296381A (ja) * 2004-04-13 2005-10-27 Nippon Kayaku Co Ltd カプセル剤の保存容器並びに保存方法
JP2008523078A (ja) * 2004-12-09 2008-07-03 インシス セラピューティクス，インコーポレーテッド 室温で安定なドロナビノール製剤
JP2006206583A (ja) * 2004-12-28 2006-08-10 Kaneka Corp 還元型補酵素ｑ１０の保存方法
US20090169586A1 (en) * 2006-03-24 2009-07-02 Ian Simon Tracton Stable packaged dosage form and process therefor
JP2010509292A (ja) * 2006-11-10 2010-03-25 ジョンソン、マッセイ、パブリック、リミテッド、カンパニー （−）−δ９−トランス−テトラヒドロカンナビノールを含んでなる組成物
JP2010535774A (ja) * 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
US20120043242A1 (en) * 2010-08-19 2012-02-23 Andrew David Hospodor Medicinal cannabis fatty foodstuff

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022085622A1 (ja) * 2020-10-23 2022-04-28 富士カプセル株式会社 カンナビジオール含有シームレスソフトカプセル

Also Published As

Publication number Publication date
EP2846782A4 (en) 2016-01-20
US8741341B2 (en) 2014-06-03
EP2846782A1 (en) 2015-03-18
WO2013169406A1 (en) 2013-11-14
CA2872248A1 (en) 2013-11-14
US20130296415A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
JP2015518494A (ja) 室温安定性ドロナビノールカプセルの製造および包装
JP5943915B2 (ja) リファキシミンの製剤およびその使用
CN102470103B (zh) 用作丙型肝炎病毒蛋白酶抑制剂的药物组合物
JP2021509670A (ja) カンナビノイドを含む医薬組成物
DK2313087T3 (en) PHARMACEUTICAL DOSAGE FORM FOR IMMEDIATE RELEASE OF AN INDOLINE DERIVATIVE
KR20110017872A (ko) 인돌리논 유도체의 현탁 제형을 포함하는 캡슐 약제학적 투여 형태
MX2007007038A (es) Formulacion de dronabinol en temperatura ambiente.
CA2363933C (en) Capsule system
WO2018112119A1 (en) Non-aqueous delta9-tetrahydrocannabinol oral liquid formulations
WO2021163023A1 (en) Stable formulations of dronabinol
KR20210114437A (ko) 경구용 박막
WO2017095736A1 (en) Aspirin soft gelatin capsule as a single active or in combination with other actives
EP2976068B1 (en) Pharmaceutical compositions comprising an active agent
CA3232209A1 (en) Compositions and methods for treating patients with dementia due to alzheimer's disease with a combination of thc and melatonin
WO2017038732A1 (ja) モンテルカストの含水医薬製剤
TW201340969A (zh) 有效ｈｃｖ抑制劑之穩定醫藥調配物
EP2949319A1 (en) Pharmaceutical compositions comprising an active agent
WO2019139864A1 (en) Methods of stabilizing dronabinol
RU2279873C2 (ru) Пероральная фармацевтическая композиция для мягких капсул, содержащая винорелбин, и способ лечения
JPWO2023044433A5 (enExample)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160303

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160303

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20161213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161220

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170808